You are here

Article metrics

Article menu
Download PDFPDF
Pancreas
Original research
ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4

 

Online download statistics by month:

Online download statistics by month: March 2021 to September 2024

AbstractFullPdf
Mar 20212072154128
Apr 20217213318
May 20211724419
Jun 2021262617
Jul 2021353113
Aug 2021312614
Sep 2021272317
Oct 20214493716
Nov 20215452824
Dec 20215053913
Jan 202211986945
Feb 202212277748
Mar 202211218544
Apr 20227127736
May 20226844320
Jun 20225225118
Jul 20224043915
Aug 20225635222
Sep 2022470256
Oct 20226105014
Nov 20225365231
Dec 20223472614
Jan 20233263312
Feb 20233252316
Mar 20232172710
Apr 20231642615
May 202312972
Jun 2023182121
Jul 2023199236
Aug 2023174221
Sep 2023228322
Oct 2023421196
Nov 2023285227
Dec 20235212921
Jan 20243321914
Feb 20243562916
Mar 20243904331
Apr 20244791613
May 20243864022
Jun 20243192014
Jul 20242922211
Aug 20241732211
Sep 20242142012
Total190891593835